Disc Medicine, Inc. (IRON)
NASDAQ: IRON · IEX Real-Time Price · USD
37.13
+3.98 (12.01%)
At close:
May 31, 2023, 4:00 PM
37.39
+0.26 (0.70%)
After-hours:
May 31, 2023, 7:47 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Selling, General & Admin | 14.04 | 5.76 | 5.87 | 6.75 |
| Research & Development | 33.44 | 25.17 | 28.17 | 34.47 |
| Operating Expenses | 47.48 | 30.93 | 34.04 | 41.23 |
| Operating Income | -47.48 | -30.93 | -34.04 | -41.23 |
| Interest Expense / Income | 0 | 0 | 6.83 | 0.35 |
| Other Expense / Income | -0.65 | 5.04 | -0.03 | -0.18 |
| Pretax Income | -46.83 | -35.97 | -40.84 | -41.4 |
| Net Income | -46.83 | -35.97 | -40.84 | -41.4 |
| Shares Outstanding (Basic) | 1 | 1 | 2 | 1 |
| Shares Outstanding (Diluted) | 1 | 1 | 2 | 1 |
| Shares Change | 18.34% | -41.89% | 192.28% | - |
| EPS (Basic) | -45.05 | -40.95 | -27.00 | -80.10 |
| EPS (Diluted) | -45.05 | -40.95 | -27.00 | -80.10 |
| Free Cash Flow Per Share | -40.79 | -31.42 | -21.65 | -74.95 |
| EBITDA | -46.53 | -35.78 | -33.69 | -40.76 |
| Depreciation & Amortization | 0.3 | 0.19 | 0.32 | 0.29 |
| EBIT | -46.83 | -35.97 | -34.01 | -41.05 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).